InsidersTradesSigma
Oryzon Genomics SA: management transactions · Spain · CNMV
CNMV:oryzon-genomics-sa-1768efES0167733015ES·CNMVMcap 232M€Healthcare
Browse the full insider trade history of Oryzon Genomics SA, a publicly traded company based in Spain. Shares trade on ES ES, under the oversight of CNMV. Operating in the Healthcare sector, Oryzon Genomics SA has logged 1 insider filings. Market capitalisation: €232.3m. The latest transaction was filed on 8 February 2024 (Other). Among the most active insiders: ANA LIMON CARRERA. Every trade is accessible without an account.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.95 €
Analyst consensus
4 analystsStrong buy
4.00 €Target 7.45 €(+153%)12.00 €
Income statement
Gross profit10.7 M€
Net income−2.6 M€-20.4% margin
Valuation
PER (forward)137.0x
P/Book1.9x
Balance sheet & cash
Market cap232.3 M€
Total debt7.6 M€
Free Cash Flow−13.4 M€
Profitability & ownership
% insiders21.3%
% institutions0.8%
Last declaration on 8 February 2024
Declarations1 total
Executives●Other35CNMV
€10,90010,000 shares@ €1.090.0047% mcap100.0% of flow
ShareXOOF
CNMV:2024020827·
1 of 1 declaration